Skip to main content
Top
Published in:

Open Access 01-12-2025 | Type 2 Diabetes | REVIEW

Advancing Type 2 Diabetes Prevention through Text-Messaging Interventions: A Narrative Review

Authors: Taynara Formagini, Christopher J. Gonzalez, Julie Dias, Elva M. Arredondo, Eric Hekler, Matthew J. O’Brien

Published in: Current Diabetes Reports | Issue 1/2025

Login to get access

Abstract

Purpose of Review

Text-messaging interventions effectively prevent and manage numerous health conditions. This scoping review evaluates recent literature on text-messaging interventions focused on diabetes prevention, highlighting their development, associated outcomes, reach, and potential sustainability.

Recent Findings

A total of 28 studies met eligibility criteria and were included in this review. Text-messaging was often used as a primary intervention method, focusing on promoting weight loss through physical activity and dietary changes. Studies also explored hybrid approaches integrating text-messaging with in-person sessions or other digital platforms. Intervention development involved multi-phase content creation, often leveraging established diabetes prevention curricula. Studies generally reported high feasibility and acceptability, although effectiveness was mixed. Cost-effectiveness comparisons favored text-messaging over traditional in-person programs. Implementation strategies aligned interventions with existing healthcare workflows, facilitating scalability and integration into routine care practices.

Summary

Text-messaging interventions demonstrate considerable promise but require further refinement to ensure their effectiveness, particularly in enhancing participant engagement to ensure effectiveness and sustainability. Future research should focus on refining intervention content, integrating interactive features, and expanding cost-effectiveness evaluations to support broader implementation in real-world settings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Knowler WCB-CE, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMedCrossRef Knowler WCB-CE, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMedCrossRef
2.
go back to reference Pan X-R, Li G-w, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.PubMedCrossRef Pan X-R, Li G-w, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.PubMedCrossRef
3.
go back to reference Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.PubMedCrossRef Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.PubMedCrossRef
4.
go back to reference Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish diabetes Prevention Study (DPS) Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–6.PubMed Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish diabetes Prevention Study (DPS) Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–6.PubMed
5.
go back to reference Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes Prevention Program? Health Aff. 2012;31(1):67–75.CrossRef Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes Prevention Program? Health Aff. 2012;31(1):67–75.CrossRef
6.
go back to reference Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015;10:1–17.CrossRef Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015;10:1–17.CrossRef
7.
go back to reference Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, et al. Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis. PLoS Med. 2016;13(7):e1002095.PubMedPubMedCentralCrossRef Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, et al. Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis. PLoS Med. 2016;13(7):e1002095.PubMedPubMedCentralCrossRef
8.
go back to reference Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4):S346–51.PubMedPubMedCentralCrossRef Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4):S346–51.PubMedPubMedCentralCrossRef
9.
go back to reference Centers for Disease Control and Prevention (CDC). Diabetes Prevention Recognition Program Application. Registry of All Recognized Organizations: U.S. Department of Health & Human Services; [ https://dprp.cdc.gov/Registry Centers for Disease Control and Prevention (CDC). Diabetes Prevention Recognition Program Application. Registry of All Recognized Organizations: U.S. Department of Health & Human Services; [ https://​dprp.​cdc.​gov/​Registry
10.
go back to reference Centers for Disease Control and Prevention (CDC). About CDC’s First National Prediabetes Awareness Campaign. U.S. Centers for Disease Control and Prevention; 2024. Centers for Disease Control and Prevention (CDC). About CDC’s First National Prediabetes Awareness Campaign. U.S. Centers for Disease Control and Prevention; 2024.
12.
go back to reference Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2021;44(1):258.CrossRef Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2021;44(1):258.CrossRef
13.
go back to reference Centers for Disease Control and Prevention (CDC). National Diabetes statistics Report. U.S. Centers for Disease Control and Prevention; 2024. Centers for Disease Control and Prevention (CDC). National Diabetes statistics Report. U.S. Centers for Disease Control and Prevention; 2024.
14.
go back to reference Ely EK, Ng BP, Cannon MJ. Delivering the National Diabetes Prevention Program: Assessment of outcomes in In-Person and virtual organizations. J Diabetes Res. 2023;2023(1):8894593.PubMedPubMedCentral Ely EK, Ng BP, Cannon MJ. Delivering the National Diabetes Prevention Program: Assessment of outcomes in In-Person and virtual organizations. J Diabetes Res. 2023;2023(1):8894593.PubMedPubMedCentral
15.
go back to reference Formagini T, Brooks JV, Roberts A, Bullard KM, Zhang Y, Saelee R, et al. Prediabetes prevalence and awareness by race, ethnicity, and educational attainment among US adults. Front Public Health. 2023;11:1277657.PubMedPubMedCentralCrossRef Formagini T, Brooks JV, Roberts A, Bullard KM, Zhang Y, Saelee R, et al. Prediabetes prevalence and awareness by race, ethnicity, and educational attainment among US adults. Front Public Health. 2023;11:1277657.PubMedPubMedCentralCrossRef
16.
go back to reference Gruss SM, Nhim K, Gregg E, Bell M, Luman E, Albright A. Public health approaches to type 2 diabetes prevention: the US National Diabetes Prevention Program and beyond. Curr Diab Rep. 2019;19:1–11.CrossRef Gruss SM, Nhim K, Gregg E, Bell M, Luman E, Albright A. Public health approaches to type 2 diabetes prevention: the US National Diabetes Prevention Program and beyond. Curr Diab Rep. 2019;19:1–11.CrossRef
17.
go back to reference Cannon MJ, Masalovich S, Ng BP, Soler RE, Jabrah R, Ely EK, et al. Retention among participants in the National Diabetes Prevention Program lifestyle change program, 2012–2017. Diabetes Care. 2020;43(9):2042–9.PubMedCrossRef Cannon MJ, Masalovich S, Ng BP, Soler RE, Jabrah R, Ely EK, et al. Retention among participants in the National Diabetes Prevention Program lifestyle change program, 2012–2017. Diabetes Care. 2020;43(9):2042–9.PubMedCrossRef
18.
go back to reference Parsons AS, Raman V, Starr B, Zezza M, Rehm CD. Medicare underpayment for diabetes Prevention Program: implications for DPP suppliers. Am J Manag Care. 2018;24(10):475–8.PubMed Parsons AS, Raman V, Starr B, Zezza M, Rehm CD. Medicare underpayment for diabetes Prevention Program: implications for DPP suppliers. Am J Manag Care. 2018;24(10):475–8.PubMed
19.
go back to reference Ritchie ND, Baucom KJ, Sauder KA. Current perspectives on the impact of the National Diabetes Prevention Program: building on successes and overcoming challenges. Diabetes, Metabolic Syndrome and Obesity. 2020:2949-57. Ritchie ND, Baucom KJ, Sauder KA. Current perspectives on the impact of the National Diabetes Prevention Program: building on successes and overcoming challenges. Diabetes, Metabolic Syndrome and Obesity. 2020:2949-57.
20.
go back to reference Bergman M, Buysschaert M, Schwarz PE, Albright A, Narayan KV, Yach D. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manage (London England). 2012;2(4):309.CrossRef Bergman M, Buysschaert M, Schwarz PE, Albright A, Narayan KV, Yach D. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manage (London England). 2012;2(4):309.CrossRef
21.
go back to reference Mohan V. National Diabetes prevention programmes in LMICs are now a necessity. Lancet Global Health. 2023;11(10):e1480–1.PubMedCrossRef Mohan V. National Diabetes prevention programmes in LMICs are now a necessity. Lancet Global Health. 2023;11(10):e1480–1.PubMedCrossRef
22.
go back to reference Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, et al. Global status of diabetes prevention and prospects for action: a consensus statement. Diab/Metab Res Rev. 2018;34(6):e3021.CrossRef Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, et al. Global status of diabetes prevention and prospects for action: a consensus statement. Diab/Metab Res Rev. 2018;34(6):e3021.CrossRef
23.
go back to reference Tuomilehto J, Uusitupa M, Gregg EW, Lindström J. Type 2 diabetes prevention programs—from proof-of-concept trials to national intervention and beyond. J Clin Med. 2023;12(5):1876.PubMedPubMedCentralCrossRef Tuomilehto J, Uusitupa M, Gregg EW, Lindström J. Type 2 diabetes prevention programs—from proof-of-concept trials to national intervention and beyond. J Clin Med. 2023;12(5):1876.PubMedPubMedCentralCrossRef
24.
go back to reference Cannon MJ, Ng BP, Lloyd K, Reynolds J, Ely EK. Delivering the National Diabetes Prevention Program: Assessment of Enrollment in In-Person and Virtual Organizations. Journal of Diabetes Research. 2022;2022. Cannon MJ, Ng BP, Lloyd K, Reynolds J, Ely EK. Delivering the National Diabetes Prevention Program: Assessment of Enrollment in In-Person and Virtual Organizations. Journal of Diabetes Research. 2022;2022.
27.
go back to reference Joiner KL, Nam S, Whittemore R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: a systematic review and meta-analysis. Prev Med. 2017;100:194–207.PubMedPubMedCentralCrossRef Joiner KL, Nam S, Whittemore R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: a systematic review and meta-analysis. Prev Med. 2017;100:194–207.PubMedPubMedCentralCrossRef
28.
go back to reference Bian RR, Piatt GA, Sen A, Plegue MA, De Michele ML, Hafez D, et al. The effect of technology-mediated diabetes prevention interventions on weight: a meta-analysis. J Med Internet Res. 2017;19(3):e76.PubMedPubMedCentralCrossRef Bian RR, Piatt GA, Sen A, Plegue MA, De Michele ML, Hafez D, et al. The effect of technology-mediated diabetes prevention interventions on weight: a meta-analysis. J Med Internet Res. 2017;19(3):e76.PubMedPubMedCentralCrossRef
29.
go back to reference Grock S, Ku J-h, Kim J, Moin T. A review of technology-assisted interventions for diabetes prevention. Curr Diab Rep. 2017;17:1–12.CrossRef Grock S, Ku J-h, Kim J, Moin T. A review of technology-assisted interventions for diabetes prevention. Curr Diab Rep. 2017;17:1–12.CrossRef
30.
go back to reference Nguyen V, Ara P, Simmons D, Osuagwu UL. The role of Digital Health Technology Interventions in the Prevention of type 2 diabetes Mellitus: a systematic review. Clin Med Insights: Endocrinol Diabetes. 2024;17:11795514241246419.PubMed Nguyen V, Ara P, Simmons D, Osuagwu UL. The role of Digital Health Technology Interventions in the Prevention of type 2 diabetes Mellitus: a systematic review. Clin Med Insights: Endocrinol Diabetes. 2024;17:11795514241246419.PubMed
31.
go back to reference Villegas V, Shah A, Manson JE, Tobias DK. Prevention of type 2 diabetes through remotely administered lifestyle programs: a systematic review. Contemp Clin Trials. 2022;119:106817.PubMedCrossRef Villegas V, Shah A, Manson JE, Tobias DK. Prevention of type 2 diabetes through remotely administered lifestyle programs: a systematic review. Contemp Clin Trials. 2022;119:106817.PubMedCrossRef
32.
go back to reference Van Rhoon L, Byrne M, Morrissey E, Murphy J, McSharry J. A systematic review of the behaviour change techniques and digital features in technology-driven type 2 diabetes prevention interventions. Digit Health. 2020;6:2055207620914427.PubMedPubMedCentralCrossRef Van Rhoon L, Byrne M, Morrissey E, Murphy J, McSharry J. A systematic review of the behaviour change techniques and digital features in technology-driven type 2 diabetes prevention interventions. Digit Health. 2020;6:2055207620914427.PubMedPubMedCentralCrossRef
33.
go back to reference Buss VH, Leesong S, Barr M, Varnfield M, Harris M. Primary prevention of cardiovascular disease and type 2 diabetes mellitus using mobile health technology: systematic review of the literature. J Med Internet Res. 2020;22(10):e21159.PubMedPubMedCentralCrossRef Buss VH, Leesong S, Barr M, Varnfield M, Harris M. Primary prevention of cardiovascular disease and type 2 diabetes mellitus using mobile health technology: systematic review of the literature. J Med Internet Res. 2020;22(10):e21159.PubMedPubMedCentralCrossRef
34.
go back to reference Teo JYC, Ramachandran HJ, Jiang Y, Seah CWA, Lim ST, Nguyen HD, et al. The characteristics and acceptance of technology-enabled diabetes prevention programs (t‐DPP) amongst individuals with prediabetes: a scoping review. J Clin Nurs. 2023;32(17–18):5562–78.PubMedCrossRef Teo JYC, Ramachandran HJ, Jiang Y, Seah CWA, Lim ST, Nguyen HD, et al. The characteristics and acceptance of technology-enabled diabetes prevention programs (t‐DPP) amongst individuals with prediabetes: a scoping review. J Clin Nurs. 2023;32(17–18):5562–78.PubMedCrossRef
35.
go back to reference Muralidharan S, Ranjani H, Anjana RM, Allender S, Mohan V. Mobile health technology in the prevention and management of type 2 diabetes. Indian J Endocrinol Metabol. 2017;21(2):334–40.CrossRef Muralidharan S, Ranjani H, Anjana RM, Allender S, Mohan V. Mobile health technology in the prevention and management of type 2 diabetes. Indian J Endocrinol Metabol. 2017;21(2):334–40.CrossRef
36.
37.
go back to reference Siopis G, Chey T, Allman-Farinelli M. A systematic review and meta‐analysis of interventions for weight management using text messaging. J Hum Nutr Dietetics. 2015;28:1–15.CrossRef Siopis G, Chey T, Allman-Farinelli M. A systematic review and meta‐analysis of interventions for weight management using text messaging. J Hum Nutr Dietetics. 2015;28:1–15.CrossRef
38.
go back to reference Smith DM, Duque L, Huffman JC, Healy BC, Celano CM. Text message interventions for physical activity: a systematic review and meta-analysis. Am J Prev Med. 2020;58(1):142–51.PubMedCrossRef Smith DM, Duque L, Huffman JC, Healy BC, Celano CM. Text message interventions for physical activity: a systematic review and meta-analysis. Am J Prev Med. 2020;58(1):142–51.PubMedCrossRef
39.
go back to reference Stowell M, Dobson R, Garner K, Baig M, Nehren N, Whittaker R. Digital interventions for self-management of prediabetes: a scoping review. PLoS ONE. 2024;19(5):e0303074.PubMedPubMedCentralCrossRef Stowell M, Dobson R, Garner K, Baig M, Nehren N, Whittaker R. Digital interventions for self-management of prediabetes: a scoping review. PLoS ONE. 2024;19(5):e0303074.PubMedPubMedCentralCrossRef
40.
go back to reference Alamnia TT, Tesfaye W, Kelly M. The effectiveness of text message delivered interventions for weight loss in developing countries: a systematic review and meta-analysis. Obes Rev. 2022;23(1):e13339.PubMedCrossRef Alamnia TT, Tesfaye W, Kelly M. The effectiveness of text message delivered interventions for weight loss in developing countries: a systematic review and meta-analysis. Obes Rev. 2022;23(1):e13339.PubMedCrossRef
41.
go back to reference Gentili A, Failla G, Melnyk A, Puleo V, Tanna GLD, Ricciardi W, et al. The cost-effectiveness of digital health interventions: a systematic review of the literature. Front Public Health. 2022;10:787135.PubMedPubMedCentralCrossRef Gentili A, Failla G, Melnyk A, Puleo V, Tanna GLD, Ricciardi W, et al. The cost-effectiveness of digital health interventions: a systematic review of the literature. Front Public Health. 2022;10:787135.PubMedPubMedCentralCrossRef
42.
go back to reference Cartujano-Barrera F, Arana-Chicas E, Ramírez-Mantilla M, Perales J, Cox LS, Ellerbeck EF et al. Every day I think about your messages: assessing text messaging engagement among latino smokers in a mobile cessation program. Patient Prefer Adherence. 2019;22(13):1213–1219. Cartujano-Barrera F, Arana-Chicas E, Ramírez-Mantilla M, Perales J, Cox LS, Ellerbeck EF et al. Every day I think about your messages: assessing text messaging engagement among latino smokers in a mobile cessation program. Patient Prefer Adherence. 2019;22(13):1213–1219.
43.
go back to reference Patton SR, Coffman MJ, De Haven MJ, Miller C, Krinner LM. Text message intervention for latino adults to improve diabetes outcomes. Hispanic Health Care Int. 2022;20(4):248–55.CrossRef Patton SR, Coffman MJ, De Haven MJ, Miller C, Krinner LM. Text message intervention for latino adults to improve diabetes outcomes. Hispanic Health Care Int. 2022;20(4):248–55.CrossRef
45.
go back to reference Rinaldi G, Hijazi A, Haghparast-Bidgoli H. Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2020;162:108084.PubMedCrossRef Rinaldi G, Hijazi A, Haghparast-Bidgoli H. Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2020;162:108084.PubMedCrossRef
46.
go back to reference MacPherson MM, Merry KJ, Locke SR, Jung ME. mHealth prompts within diabetes prevention programs: a scoping review. Mhealth. 2022;8. MacPherson MM, Merry KJ, Locke SR, Jung ME. mHealth prompts within diabetes prevention programs: a scoping review. Mhealth. 2022;8.
47.
go back to reference Perng W, Conway R, Mayer-Davis E, Dabelea D. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care. 2023;46(3):490–9.PubMedPubMedCentralCrossRef Perng W, Conway R, Mayer-Davis E, Dabelea D. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care. 2023;46(3):490–9.PubMedPubMedCentralCrossRef
48.
go back to reference Covidence systematic review software, Melbourne. Australia: Veritas Health Innovation; [Available from: www.covidence.org. Covidence systematic review software, Melbourne. Australia: Veritas Health Innovation; [Available from: www.covidence.org.
49.
go back to reference Cheung NW, Simmons D, Marschner S, Thiagalingam A, Pasupathy D, Smith BJ, et al. Randomised controlled trial of a Customised text messaging and activity monitor program for Lifestyle Improvement after Gestational Diabetes. Nutrients. 2024;16(6):820.PubMedPubMedCentralCrossRef Cheung NW, Simmons D, Marschner S, Thiagalingam A, Pasupathy D, Smith BJ, et al. Randomised controlled trial of a Customised text messaging and activity monitor program for Lifestyle Improvement after Gestational Diabetes. Nutrients. 2024;16(6):820.PubMedPubMedCentralCrossRef
50.
go back to reference Bootwong P, Intarut N. The effects of text messages for promoting physical activities in prediabetes: a randomized controlled trial. Telemedicine e-Health. 2022;28(6):896–903.PubMed Bootwong P, Intarut N. The effects of text messages for promoting physical activities in prediabetes: a randomized controlled trial. Telemedicine e-Health. 2022;28(6):896–903.PubMed
51.
go back to reference Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, et al. Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial. BMC Med. 2021;19(1):130.PubMedPubMedCentralCrossRef Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, et al. Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial. BMC Med. 2021;19(1):130.PubMedPubMedCentralCrossRef
52.
go back to reference Staite E, Bayley A, Al-Ozairi E, Stewart K, Hopkins D, Rundle J, et al. A wearable technology delivering a web-based diabetes prevention program to people at high risk of type 2 diabetes: randomized controlled trial. JMIR mHealth uHealth. 2020;8(7):e15448.PubMedPubMedCentralCrossRef Staite E, Bayley A, Al-Ozairi E, Stewart K, Hopkins D, Rundle J, et al. A wearable technology delivering a web-based diabetes prevention program to people at high risk of type 2 diabetes: randomized controlled trial. JMIR mHealth uHealth. 2020;8(7):e15448.PubMedPubMedCentralCrossRef
53.
go back to reference Nanditha A, Thomson H, Susairaj P, Srivanichakorn W, Oliver N, Godsland IF, et al. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial. Diabetologia. 2020;63:486–96.PubMedPubMedCentralCrossRef Nanditha A, Thomson H, Susairaj P, Srivanichakorn W, Oliver N, Godsland IF, et al. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial. Diabetologia. 2020;63:486–96.PubMedPubMedCentralCrossRef
54.
go back to reference Brown SA, Winter MA, Becker HA, García AA, Velasquez MM, Tanaka H, et al. Transitioning from an In-Person intervention to Augmented text Messaging during COVID-19 in Mexican americans with prediabetes: the Starr County Diabetes Prevention Randomized Clinical Trial. Sci Diabetes Self-management Care. 2024;50(2):107–15.CrossRef Brown SA, Winter MA, Becker HA, García AA, Velasquez MM, Tanaka H, et al. Transitioning from an In-Person intervention to Augmented text Messaging during COVID-19 in Mexican americans with prediabetes: the Starr County Diabetes Prevention Randomized Clinical Trial. Sci Diabetes Self-management Care. 2024;50(2):107–15.CrossRef
55.
go back to reference Arora S, Lam CN, Burner E, Menchine M. Implementation and evaluation of an Automated text message–based Diabetes Prevention Program for adults with pre-diabetes. J Diabetes Sci Technol. 2024;18(5):1139–45. Arora S, Lam CN, Burner E, Menchine M. Implementation and evaluation of an Automated text message–based Diabetes Prevention Program for adults with pre-diabetes. J Diabetes Sci Technol. 2024;18(5):1139–45.
56.
go back to reference Formagini T, Teruel Camargo J, Perales-Puchalt J, Drees BM, Fracachan Cabrera M, Ramírez M. A culturally and linguistically adapted text-message diabetes Prevention Program for latinos: feasibility, acceptability, and preliminary effectiveness. Translational Behav Med. 2024;14(2):138–47.CrossRef Formagini T, Teruel Camargo J, Perales-Puchalt J, Drees BM, Fracachan Cabrera M, Ramírez M. A culturally and linguistically adapted text-message diabetes Prevention Program for latinos: feasibility, acceptability, and preliminary effectiveness. Translational Behav Med. 2024;14(2):138–47.CrossRef
57.
go back to reference Stewart JL, Hatzigeorgiou C, Davis CL, Ledford CJ. DPPFit: developing and testing a technology-based adaptation of the Diabetes Prevention Program (DPP) to address prediabetes in a primary care setting. J Am Board Family Med. 2022;35(3):548–58.CrossRef Stewart JL, Hatzigeorgiou C, Davis CL, Ledford CJ. DPPFit: developing and testing a technology-based adaptation of the Diabetes Prevention Program (DPP) to address prediabetes in a primary care setting. J Am Board Family Med. 2022;35(3):548–58.CrossRef
58.
go back to reference Fischer HH, Durfee MJ, Raghunath SG, Ritchie ND. Short message service text message support for weight loss in patients with prediabetes: pragmatic trial. JMIR Diabetes. 2019;4(2):e12985.PubMedPubMedCentralCrossRef Fischer HH, Durfee MJ, Raghunath SG, Ritchie ND. Short message service text message support for weight loss in patients with prediabetes: pragmatic trial. JMIR Diabetes. 2019;4(2):e12985.PubMedPubMedCentralCrossRef
59.
go back to reference Stephens TN, Joerin A, Rauws M, Werk LN. Feasibility of pediatric obesity and prediabetes treatment support through Tess, the AI behavioral coaching chatbot. Translational Behav Med. 2019;9(3):440–7.CrossRef Stephens TN, Joerin A, Rauws M, Werk LN. Feasibility of pediatric obesity and prediabetes treatment support through Tess, the AI behavioral coaching chatbot. Translational Behav Med. 2019;9(3):440–7.CrossRef
60.
go back to reference Kim MT, Kim KB, Nguyen TH, Ko J, Zabora J, Jacobs E, et al. Motivating people to sustain healthy lifestyles using persuasive technology: a pilot study of Korean americans with prediabetes and type 2 diabetes. Patient Educ Couns. 2019;102(4):709–17.PubMedCrossRef Kim MT, Kim KB, Nguyen TH, Ko J, Zabora J, Jacobs E, et al. Motivating people to sustain healthy lifestyles using persuasive technology: a pilot study of Korean americans with prediabetes and type 2 diabetes. Patient Educ Couns. 2019;102(4):709–17.PubMedCrossRef
61.
go back to reference Rollo ME, Baldwin JN, Hutchesson M, Aguiar EJ, Wynne K, Young A, et al. The feasibility and preliminary efficacy of an eHealth lifestyle program in women with recent gestational diabetes mellitus: a pilot study. Int J Environ Res Public Health. 2020;17(19):7115.PubMedPubMedCentralCrossRef Rollo ME, Baldwin JN, Hutchesson M, Aguiar EJ, Wynne K, Young A, et al. The feasibility and preliminary efficacy of an eHealth lifestyle program in women with recent gestational diabetes mellitus: a pilot study. Int J Environ Res Public Health. 2020;17(19):7115.PubMedPubMedCentralCrossRef
62.
go back to reference Cheung NW, Blumenthal C, Smith BJ, Hogan R, Thiagalingam A, Redfern J, et al. A pilot randomised controlled trial of a text messaging intervention with customisation using linked data from wireless wearable activity monitors to improve risk factors following gestational diabetes. Nutrients. 2019;11(3):590.PubMedPubMedCentralCrossRef Cheung NW, Blumenthal C, Smith BJ, Hogan R, Thiagalingam A, Redfern J, et al. A pilot randomised controlled trial of a text messaging intervention with customisation using linked data from wireless wearable activity monitors to improve risk factors following gestational diabetes. Nutrients. 2019;11(3):590.PubMedPubMedCentralCrossRef
63.
go back to reference Ritchie ND, Gutiérrez-Raghunath S, Durfee MJ, Fischer H. Supplemental text message support with the National Diabetes Prevention Program: pragmatic comparative effectiveness trial. JMIR mHealth uHealth. 2020;8(6):e15478.PubMedPubMedCentralCrossRef Ritchie ND, Gutiérrez-Raghunath S, Durfee MJ, Fischer H. Supplemental text message support with the National Diabetes Prevention Program: pragmatic comparative effectiveness trial. JMIR mHealth uHealth. 2020;8(6):e15478.PubMedPubMedCentralCrossRef
64.
go back to reference Vargas MC, Pineda GJ, Talamantes V, Toledo MJL, Owen A, Carcamo P, et al. Design and rationale of behavioral nudges for diabetes prevention (BEGIN): a pragmatic, cluster randomized trial of text messaging and a decision aid intervention for primary care patients with prediabetes. Contemp Clin Trials. 2023;130:107216.PubMedPubMedCentralCrossRef Vargas MC, Pineda GJ, Talamantes V, Toledo MJL, Owen A, Carcamo P, et al. Design and rationale of behavioral nudges for diabetes prevention (BEGIN): a pragmatic, cluster randomized trial of text messaging and a decision aid intervention for primary care patients with prediabetes. Contemp Clin Trials. 2023;130:107216.PubMedPubMedCentralCrossRef
65.
go back to reference Carter EW, Vadari HS, Stoll S, Rogers B, Resnicow K, Heisler M, et al. Study protocol: behavioral economics and self-determination theory to change diabetes risk (BEST change). Contemp Clin Trials. 2023;124:107038.PubMedCrossRef Carter EW, Vadari HS, Stoll S, Rogers B, Resnicow K, Heisler M, et al. Study protocol: behavioral economics and self-determination theory to change diabetes risk (BEST change). Contemp Clin Trials. 2023;124:107038.PubMedCrossRef
66.
go back to reference Galmes-Panades AM, Angullo E, Mira-Martínez S, Bennasar-Veny M, Zamanillo-Campos R, Gómez-Juanes R, et al. Development and evaluation of a digital health intervention to prevent type 2 diabetes in primary care: the PREDIABETEXT study protocol for a randomised clinical trial. Int J Environ Res Public Health. 2022;19(22):14706.PubMedPubMedCentralCrossRef Galmes-Panades AM, Angullo E, Mira-Martínez S, Bennasar-Veny M, Zamanillo-Campos R, Gómez-Juanes R, et al. Development and evaluation of a digital health intervention to prevent type 2 diabetes in primary care: the PREDIABETEXT study protocol for a randomised clinical trial. Int J Environ Res Public Health. 2022;19(22):14706.PubMedPubMedCentralCrossRef
67.
go back to reference Catley D, Puoane T, Tsolekile L, Resnicow K, Fleming K, Hurley EA, et al. Adapting the Diabetes Prevention Program for low and middle-income countries: protocol for a cluster randomised trial to evaluate ‘Lifestyle Africa’. BMJ Open. 2019;9(11):e031400.PubMedPubMedCentralCrossRef Catley D, Puoane T, Tsolekile L, Resnicow K, Fleming K, Hurley EA, et al. Adapting the Diabetes Prevention Program for low and middle-income countries: protocol for a cluster randomised trial to evaluate ‘Lifestyle Africa’. BMJ Open. 2019;9(11):e031400.PubMedPubMedCentralCrossRef
68.
go back to reference Alzeidan R, Shata Z, Hassounah MM, Baghdadi LR, Hersi A, Fayed A, et al. Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial. BMC Public Health. 2019;19:1–11.CrossRef Alzeidan R, Shata Z, Hassounah MM, Baghdadi LR, Hersi A, Fayed A, et al. Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial. BMC Public Health. 2019;19:1–11.CrossRef
69.
go back to reference Gupta Y, Kapoor D, Josyula L, Praveen D, Naheed A, Desai A, et al. A lifestyle intervention programme for the prevention of type 2 diabetes mellitus among south Asian women with gestational diabetes mellitus [LIVING study]: protocol for a randomized trial. Diabet Med. 2019;36(2):243–51.PubMedCrossRef Gupta Y, Kapoor D, Josyula L, Praveen D, Naheed A, Desai A, et al. A lifestyle intervention programme for the prevention of type 2 diabetes mellitus among south Asian women with gestational diabetes mellitus [LIVING study]: protocol for a randomized trial. Diabet Med. 2019;36(2):243–51.PubMedCrossRef
70.
go back to reference Sinclair Ki, Carty C, Gonzales K, Nikolaus C, Gillespie L, Buchwald D. Strong men, strong communities: design of a randomized controlled trial of a diabetes prevention intervention for American Indian and Alaska native men. Am J Men’s Health. 2020;14(4):1557988320945457.CrossRef Sinclair Ki, Carty C, Gonzales K, Nikolaus C, Gillespie L, Buchwald D. Strong men, strong communities: design of a randomized controlled trial of a diabetes prevention intervention for American Indian and Alaska native men. Am J Men’s Health. 2020;14(4):1557988320945457.CrossRef
71.
go back to reference Soltero EG, Lopez C, Musaad SM, O’Connor TM, Thompson D. Fit24, a digital health intervention to reduce type 2 diabetes risk among hispanic youth: protocol for a feasibility pilot study. Contemp Clin Trials. 2023;127:107117.PubMedPubMedCentralCrossRef Soltero EG, Lopez C, Musaad SM, O’Connor TM, Thompson D. Fit24, a digital health intervention to reduce type 2 diabetes risk among hispanic youth: protocol for a feasibility pilot study. Contemp Clin Trials. 2023;127:107117.PubMedPubMedCentralCrossRef
72.
go back to reference MacPherson MM, Cranston KD, Locke SR, Bourne JE, Jung ME. Using the behavior change wheel to develop text messages to promote diet and physical activity adherence following a diabetes prevention program. Translational Behav Med. 2021;11(8):1585–95.CrossRef MacPherson MM, Cranston KD, Locke SR, Bourne JE, Jung ME. Using the behavior change wheel to develop text messages to promote diet and physical activity adherence following a diabetes prevention program. Translational Behav Med. 2021;11(8):1585–95.CrossRef
73.
go back to reference Rodriguez DV, Lawrence K, Luu S, Yu JL, Feldthouse DM, Gonzalez J, et al. Development of a computer-aided text message platform for user engagement with a digital diabetes Prevention Program: a case study. J Am Med Inform Assoc. 2022;29(1):155–62.CrossRef Rodriguez DV, Lawrence K, Luu S, Yu JL, Feldthouse DM, Gonzalez J, et al. Development of a computer-aided text message platform for user engagement with a digital diabetes Prevention Program: a case study. J Am Med Inform Assoc. 2022;29(1):155–62.CrossRef
74.
go back to reference Hill J, Faber M, George C, Peer N, Mulabisano T, Mostert S, et al. The development of text messages to support people at risk of diabetes in Low-Resourced communities: the South African diabetes Prevention Programme. Nutrients. 2023;15(21):4692.PubMedPubMedCentralCrossRef Hill J, Faber M, George C, Peer N, Mulabisano T, Mostert S, et al. The development of text messages to support people at risk of diabetes in Low-Resourced communities: the South African diabetes Prevention Programme. Nutrients. 2023;15(21):4692.PubMedPubMedCentralCrossRef
75.
go back to reference Soltero E, Lopez C, Mihail S, Hernandez A, Musaad SM, O’Connor TM, et al. An SMS text message–based type 2 diabetes Prevention Program for hispanic adolescents with obesity: qualitative co-design process. JMIR Formative Res. 2023;7(1):e46606.CrossRef Soltero E, Lopez C, Mihail S, Hernandez A, Musaad SM, O’Connor TM, et al. An SMS text message–based type 2 diabetes Prevention Program for hispanic adolescents with obesity: qualitative co-design process. JMIR Formative Res. 2023;7(1):e46606.CrossRef
76.
go back to reference MacPherson M, Cranston K, Johnston C, Locke S, Jung ME. Evaluation and refinement of a bank of SMS text messages to promote behavior change adherence following a diabetes prevention program: survey study. JMIR Formative Res. 2021;5(8):e28163.CrossRef MacPherson M, Cranston K, Johnston C, Locke S, Jung ME. Evaluation and refinement of a bank of SMS text messages to promote behavior change adherence following a diabetes prevention program: survey study. JMIR Formative Res. 2021;5(8):e28163.CrossRef
77.
go back to reference Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP) description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–71.CrossRef Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP) description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–71.CrossRef
79.
go back to reference Taylor SE. Social support: a review. Oxf Handb Health Psychol. 2011;1:189–214. Taylor SE. Social support: a review. Oxf Handb Health Psychol. 2011;1:189–214.
80.
go back to reference Baucom KJ, Bauman T, Gutierrez Chavez M, Nemirovsky Y, Aguirre MC, Ramos C, et al. Barriers to participation and lifestyle change among lower versus higher income participants in the National Diabetes Prevention Program: lifestyle coach perspectives. Translational Behav Med. 2022;12(8):860–9.CrossRef Baucom KJ, Bauman T, Gutierrez Chavez M, Nemirovsky Y, Aguirre MC, Ramos C, et al. Barriers to participation and lifestyle change among lower versus higher income participants in the National Diabetes Prevention Program: lifestyle coach perspectives. Translational Behav Med. 2022;12(8):860–9.CrossRef
81.
go back to reference Bishop J, Irby MB, Isom S, Blackwell CS, Vitolins MZ, Skelton JA. Diabetes prevention, weight loss, and social support: program participants’ perceived influence on the health behaviors of their social support system. Fam Community Health. 2013;36(2):158–71.PubMedCrossRef Bishop J, Irby MB, Isom S, Blackwell CS, Vitolins MZ, Skelton JA. Diabetes prevention, weight loss, and social support: program participants’ perceived influence on the health behaviors of their social support system. Fam Community Health. 2013;36(2):158–71.PubMedCrossRef
82.
go back to reference O’Neal LJ, Scarton L, Dhar B. Group social support facilitates adoption of healthier behaviors among black women in a community-initiated national diabetes prevention program. Health Promot Pract. 2022;23(6):916–9.PubMedCrossRef O’Neal LJ, Scarton L, Dhar B. Group social support facilitates adoption of healthier behaviors among black women in a community-initiated national diabetes prevention program. Health Promot Pract. 2022;23(6):916–9.PubMedCrossRef
83.
go back to reference McCurley JL, Gutierrez AP, Gallo LC. Diabetes prevention in US hispanic adults: a systematic review of culturally tailored interventions. Am J Prev Med. 2017;52(4):519–29.PubMedCrossRef McCurley JL, Gutierrez AP, Gallo LC. Diabetes prevention in US hispanic adults: a systematic review of culturally tailored interventions. Am J Prev Med. 2017;52(4):519–29.PubMedCrossRef
84.
go back to reference Zare H, Delgado P, Spencer M, Thorpe RJ Jr, Thomas L, Gaskin DJ, et al. Using Community Health Workers to address barriers to Participation and Retention in Diabetes Prevention Program: a Concept Paper. J Prim Care Community Health. 2022;13:21501319221134563.PubMedPubMedCentralCrossRef Zare H, Delgado P, Spencer M, Thorpe RJ Jr, Thomas L, Gaskin DJ, et al. Using Community Health Workers to address barriers to Participation and Retention in Diabetes Prevention Program: a Concept Paper. J Prim Care Community Health. 2022;13:21501319221134563.PubMedPubMedCentralCrossRef
85.
go back to reference O’Mara-Eves A, Brunton G, Oliver S, Kavanagh J, Jamal F, Thomas J. The effectiveness of community engagement in public health interventions for disadvantaged groups: a meta-analysis. BMC Public Health. 2015;15:1–23.CrossRef O’Mara-Eves A, Brunton G, Oliver S, Kavanagh J, Jamal F, Thomas J. The effectiveness of community engagement in public health interventions for disadvantaged groups: a meta-analysis. BMC Public Health. 2015;15:1–23.CrossRef
86.
go back to reference Gunn CM, Martinez LSS, Battaglia TA, Lobb R, Chassler D, Hakim D, et al. Integrating community engagement with implementation science to advance the measurement of translational science. J Clin Translational Sci. 2022;6(1):e107.CrossRef Gunn CM, Martinez LSS, Battaglia TA, Lobb R, Chassler D, Hakim D, et al. Integrating community engagement with implementation science to advance the measurement of translational science. J Clin Translational Sci. 2022;6(1):e107.CrossRef
87.
go back to reference Lythreatis S, Singh SK, El-Kassar A-N. The digital divide: a review and future research agenda. Technol Forecast Soc Chang. 2022;175:121359.CrossRef Lythreatis S, Singh SK, El-Kassar A-N. The digital divide: a review and future research agenda. Technol Forecast Soc Chang. 2022;175:121359.CrossRef
Metadata
Title
Advancing Type 2 Diabetes Prevention through Text-Messaging Interventions: A Narrative Review
Authors
Taynara Formagini
Christopher J. Gonzalez
Julie Dias
Elva M. Arredondo
Eric Hekler
Matthew J. O’Brien
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 1/2025
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-024-01568-w

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more